Peregrine Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$33.11 - $55.01 $4.19 Million - $6.96 Million	-126,613 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$50.07 - $66.05 $1.22 Million - $1.61 Million	-24,387 Reduced 16.15%	126,613 $6.34 Million
Q2 2021 Aug 03, 2021	SELL	$56.61 - $80.46 $289,446 - $411,391	-5,113 Reduced 3.28%	151,000 $9.51 Million
Q1 2021 May 11, 2021	SELL	$86.23 - $125.19 $1.79 Million - $2.6 Million	-20,778 Reduced 11.75%	156,113 $14.5 Million
Q4 2020 Jan 19, 2021	BUY	$79.17 - $111.47 $2.4 Million - $3.37 Million	30,266 Added 20.64%	176,891 $15.8 Million
Q3 2020 Oct 20, 2020	SELL	$81.91 - $134.94 $6.02 Million - $9.91 Million	-73,463 Reduced 33.38%	146,625 $15.2 Million
Q2 2020 Jul 30, 2020	SELL	$54.33 - $89.52 $1.36 Million - $2.25 Million	-25,107 Reduced 10.24%	220,088 $17.4 Million
Q1 2020 Apr 17, 2020	SELL	$49.34 - $68.76 $2.61 Million - $3.63 Million	-52,850 Reduced 17.73%	245,195 $14.2 Million
Q4 2019 Jan 16, 2020	SELL	$51.21 - $59.06 $176,264 - $203,284	-3,442 Reduced 1.14%	298,045 $16.1 Million
Q3 2019 Oct 16, 2019	SELL	$40.6 - $57.2 $909,358 - $1.28 Million	-22,398 Reduced 6.92%	301,487 $15.8 Million
Q2 2019 Jul 18, 2019	BUY	$39.92 - $53.86 $1.03 Million - $1.39 Million	25,799 Added 8.65%	323,885 $0
Q1 2019 Apr 12, 2019	BUY	$48.23 - $66.16 $1.46 Million - $2.01 Million	30,346 Added 11.33%	298,086 $0
Q4 2018 Jan 17, 2019	SELL	$55.63 - $73.24 $2.36 Million - $3.11 Million	-42,473 Reduced 13.69%	267,740 $15.9 Million
Q3 2018 Oct 18, 2018	SELL	$52.05 - $66.51 $1.01 Million - $1.29 Million	-19,407 Reduced 5.89%	310,213 $0
Q2 2018 Jul 12, 2018	SELL	$48.33 - $55.64 $935,088 - $1.08 Million	-19,348 Reduced 5.54%	329,620 $0
Q1 2018 Apr 16, 2018	SELL	$44.44 - $54.39 $764,456 - $935,616	-17,202 Reduced 4.7%	348,968 $0
Q4 2017 Jan 24, 2018	SELL	$37.77 - $47.75 $3.35 Million - $4.23 Million	-88,687 Reduced 19.5%	366,170 $0
Q3 2017 Oct 25, 2017	BUY	$34.14 - $40.45 $15.5 Million - $18.4 Million	454,857	454,857 $0

Others Institutions Holding EBS

# of Institutions

168

Shares Held

36.3M

Call Options Held

352K

Put Options Held

770K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $485M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account